Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients

Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients treated with AR-directed therapy
Pradeep Chauhan - CGC 2023 Annual Meeting
The Cancer Genomics Consortium (CGC - cancergenomics...) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Our vision is for all cancer patients to be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy. CGC aims to be the authoritative organization for guidance on the best practice of clinical cancer genomic testing. Please visit www.cancergeno.... to become a member and gain full access to our complete library of presentations.